Olympus Corp - Net Worth and Insider Trading

Olympus Corp Net Worth

The estimated net worth of Olympus Corp is at least $690 dollars as of 2024-11-13. Olympus Corp is the 10% Owner of Plus Therapeutics Inc and owns about 535 shares of Plus Therapeutics Inc (PSTV) stock worth over $690. Details can be seen in Olympus Corp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Olympus Corp has not made any transactions after 2008-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Olympus Corp

To

Olympus Corp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Olympus Corp owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .

Click here to see the complete history of Olympus Corp’s form 4 insider trades.

Insider Ownership Summary of Olympus Corp

Ticker Comapny Transaction Date Type of Owner
PSTV Plus Therapeutics Inc 2008-08-07 10 percent owner

Olympus Corp Latest Holdings Summary

Olympus Corp currently owns a total of 1 stock. Olympus Corp owns 535 shares of Plus Therapeutics Inc (PSTV) as of August 7, 2008, with a value of $690.

Latest Holdings of Olympus Corp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTV Plus Therapeutics Inc 2008-08-07 535 1.29 690

Holding Weightings of Olympus Corp


Olympus Corp Form 4 Trading Tracker

According to the SEC Form 4 filings, Olympus Corp has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 133 shares on August 7, 2008, which cost Olympus Corp around $6 Million.

Insider Trading History of Olympus Corp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Olympus Corp Trading Performance

GuruFocus tracks the stock performance after each of Olympus Corp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Olympus Corp is -33.2%. GuruFocus also compares Olympus Corp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Olympus Corp within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Olympus Corp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Olympus Corp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -19.02 LIMIT LIMIT LIMIT LIMIT LIMIT

Olympus Corp Ownership Network

Ownership Network List of Olympus Corp

No Data

Ownership Network Relation of Olympus Corp

Insider Network Chart

Olympus Corp Owned Company Details

What does Plus Therapeutics Inc do?

Who are the key executives at Plus Therapeutics Inc?

Olympus Corp is the 10 percent owner of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .

Plus Therapeutics Inc (PSTV) Insider Trades Summary

Over the past 18 months, Olympus Corp made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 22,797 shares made by Howard Clowes , and a net purchase of 44,755 shares made by Greg Petersen .

In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 39,883 shares, with a net purchase of 39,883 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 140,755 shares were bought by its insiders, resulting in a net purchase of 138,687 shares.

Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Plus Therapeutics Inc Insider Transactions

No Available Data

Olympus Corp Mailing Address

Above is the net worth, insider trading, and ownership report for Olympus Corp. You might contact Olympus Corp via mailing address: Shinjuku Monolith, 3-1 Nishi-shinjuku 2-chome, Shinjuku-ku, Tokyo M0 163-0914.